Skip to main content
Home
  • Clinical Outcome Assessments
    Clinical Outcome Assessments

    What are Clinical Outcome Assessments (COAs)? What do they measure?

    Learn more about COAs
    hero_1.jpeg
    The most trusted distributor of COAs

    700+ exclusive COA distributions on behalf of their copyright owners

    hero_2.jpeg
    PROQOLID™: the largest COA database

    7,000+ COAs described in details and accessible in this unique database

  • Services
    Services

    Mapi Research Trust provides turnkey solutions for your Clinical Outcome Assessments (COAs) strategies - including COA databases, targeted literature reviews, licensing.

    Read More
    COA Databases Patient-Centered Endpoint Intelligence COA Licensing Translation and Linguistic Validation eCOA Licensing COA Repository
    hero_3.jpeg
    About ePROVIDE™

    Online access to all our services and COA databases

    hero_2_2.jpeg
    What are eBooklets?

    Find out more about this step-by-step guidance for valid digitization of COAs

  • Author Collaboration
    Author Collaboration

    Our team is dedicated to assisting authors in the daily management of their questionnaires and all derivatives, including translations and electronic versions

    Read More
    COA distribution COA copyright and protection Promotion of COAs and developers Testimonials
    hero_3_1.jpeg
    Catalog of COAs distributed by Mapi Research Trust

    800+ exclusive distributions of COAs, accessible in ePROVIDE

  • Resources
    Resources

    ACCESS all our resources on COAs and eCOA: webinars, publications, blogs. SUBSCRIBE to receive email updates.

    Read More
    Blog Publications Useful links Webinar recordings Whitepapers
    Whitepaper-Digitizing-COAs.jpg
    New whitepaper

    Digitizing COAs: A streamlined approach to approval

    hero_4_2.jpeg
    New whitepaper

    COAs and copyright: How to mitigate risks of infringement and misuse in clinical research and practice

  • News & Events
    News & Events

    Stay informed with our latest news and check all our upcoming events. SUBSCRIBE to get email updates.

    Read More
    hero_5_1.jpeg
    News
    Hero_5_2.jpeg
    Conferences
    Hero_5_3.jpeg
    Webinars
  • About us
    About us

    Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Clinical Outcome Assessments(COAs).

    Read More
    hero_6_1.jpeg
    Team

    A global team of multi-disciplinary experts

    hero_6_2.jpeg
    Experience

    Collecting & Processing Patient Centered Outcomes information for more than two decades

  • Contact
  1. Home
  2. Resources
  3. Blog
  4. FDA & EMA COA qualification programs

FDA & EMA COA qualification programs: Regulators’ opinion to facilitate COA selection in drug development

  • 07 August 2024

When it comes to developing Clinical Outcome Assessment (COA) strategies in the drug approval journey, the industry and researchers are often faced with many barriers. The challenges include selecting the right tool to assess the target concepts of interest for the intended population, limiting burden on patients and missing data, analyzing and interpretation of COA data, and meeting regulators’ COA requirements.

Over the last years, the FDA and EMA have worked on clarifying their expectations to better guide drug developers towards a successful regulatory decision-making.

A major milestone was the June 2020 release of the first guidance of the FDA’s “Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making”.

In parallel, the EMA and FDA also provide valuable advice to support the qualification of Clinical Outcome Assessments for a specific intended use in the context of research:

  • The FDA COA qualification program aims at providing a regulatory conclusion on the reliability of a COA, as stated on the FDA’s website in October 2023 “the program represents a conclusion that within the stated context of use, results of assessment can be relied upon to measure a specific concept and have a specific interpretation and application in drug development and regulatory decision-making.” (accessed on November 18, 2023)
  • The EMA qualification program intends at publishing an opinion on novel methodologies, as stated on the EMA’s website “the program represents the opinions on the qualification of innovative development methods and letters of support for novel methodologies that have been shown to be promising in the context of research and development into pharmaceuticals.” (accessed on November 18, 2023)

 

FDA & EMA qualification programs at a glance

 

FDA qualification program

EMA qualification program

Qualification definition

COA qualification is a regulatory conclusion that the COA is a well-defined and reliable assessment of a specified concept of interest for use in adequate and well-controlled studies in a specified context of use

  • Qualification opinions: opinion on the acceptability of a specific use of a method
  • Letters of support: proposed when the novel methodology under evaluation cannot yet be qualified but is shown to be promising based on preliminary data

 

Acknowledged COAs

  • 9 qualified COAs (all PROs*)
  • 41 COAs accepted in the qualification process (Letter of Intent accepted)
  • 4 qualification opinions (1 PerfO*, 1 ClinRO*, 2 PROs*)
  • 11 Letters of support

Major therapeutic areas covered by acknowledged COAs

  • Digestive System Diseases (eg. Pediatric Eosinophilic Esophagitis Symptom Severity Module - PEESS)
  • Respiratory Tract Diseases (eg. Community-Acquired Bacterial Pneumonia Symptom Diary - PneumoPRO©)
  • Mental Disorders (eg. Symptoms of Major Depressive Disorder Scale - SMDDS)
  • Digestive System Diseases (eg. Pediatric ulcerative colitis activity index - PUCAI)
  • Respiratory Tract Diseases (eg. Pulmonary Arterial Hypertension-Symptoms and Impact Questionnaire - PAH-SYMPACT®)
  • Mental Disorders (eg. ABS-II Adaptive Behavior Composite - VABS-II-ABC)

Major concepts assessed by acknowledged COAs

Symptoms, pain, and physical functioning

Symptoms, social and emotional functioning

*PRO: Patient-Reported Outcome, PerfO: Performance-Reported Outcome, ClinRO: Clinician-Reported Outcome

 

PROQOLID™: FDA/EMA qualified COAs at your fingertips

PROQOLID™ is a unique and comprehensive online database providing information about the development, the validity, the content, the translations, the copyright and the conditions of use of 6,000+ COAs.

You can now easily identify FDA/EMA qualified COAs in PROQOLID™ through newly developed search filters (“FDA qualified COA”, “COA accepted in the FDA qualification program”; “COA with an EMA opinion” and “COA with an EMA letter of support”) and retrieve a full set of key information about the instruments.

To get access to the full list of qualified COAs, subscribe to PROQOLID™ in the ePROVIDE™ platform.

 

Visit ePROVIDE™
In this section
In this section
  • Blog
  • Publications
    • PROQOLID
    • PROLABELS
    • Literature Review
    • Intellectual Property, copyright issues, and distribution of Patient-Centered Outcomes
    • Translation & Linguistic validation
    • Therapeutic areas
      • Digestive health, gastroenterology, metabolism
      • Endocrinology
      • General
      • Gynecology
      • Hematology
      • Infectious disease, immunology, vaccines
      • Ophthalmology
      • Pain
      • Psychiatry-psychology
      • Rare Diseases
      • Respiratory
      • Rheumatology–musculoskeletal disorders
      • Urology
    • Cochrane HRQoL Methods Group
    • Development projects
    • Education
    • ERIQA/PRO harmonization
    • IQOD
  • Useful links
  • Webinar recordings
  • Whitepapers
    • Whitepaper | COAs and copyright
    • The COA licensing process: How to prepare for success
    • Whitepaper | Digitizing COAs: A streamlined approach to approval

Related information

Webpage

FDA qualification program

Webpage

EMA qualification program

Site Branding
    ICON plc
  • Contact
  • About Us
For Clients
  • Services
  • Resources
  • ePROVIDE™
News & Events
  • News
  • Conferences
  • Webinars
Socials
  • Linkedin

Legal Footer

  • © 2025 Mapi Research Trust
  • Disclaimer
  • Privacy
  • Site Cookies
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption